يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Giulia Vivaldi"', وقت الاستعلام: 1.34s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)

    المؤلفون: Giulia Vivaldi, David A. Jolliffe, Hayley Holt, Florence Tydeman, Mohammad Talaei, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Adrian R. Martineau

    المصدر: The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100501- (2022)

    مصطلحات موضوعية: SARS-CoV-2, Vaccination, Breakthrough infection, ChAdOx1, BNT162b2, mRNA-1273, Public aspects of medicine, RA1-1270

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2666776222001971; https://doaj.org/toc/2666-7762

    URL الوصول: https://doaj.org/article/0ba04dd374404b5295f2d985a99d0f28

    Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273:A population-based cohort study (COVIDENCE UK)

    المؤلفون: Giulia Vivaldi, David A. Jolliffe, Hayley Holt, Florence Tydeman, Mohammad Talaei, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Adrian R. Martineau

    المصدر: Vivaldi, G, Jolliffe, D A, Holt, H, Tydeman, F, Talaei, M, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273 : A population-based cohort study (COVIDENCE UK) ', The Lancet Regional Health Europe, vol. 22, 100501, pp. 100501 . https://doi.org/10.1016/j.lanepe.2022.100501
    Vivaldi, G, Jolliffe, D A, Holt, H, Tydeman, F, Talaei, M, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) ', The Lancet regional health. Europe, vol. 22, 100501 . https://doi.org/10.1016/j.lanepe.2022.100501

    مصطلحات موضوعية: mRNA-1273, Oncology, SDG 3 - Good Health and Well-being, SARS-CoV-2, Health Policy, Vaccination, Internal Medicine, BNT162b2, ChAdOx1, Breakthrough infection

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d884e85d49c61c056373699742623dd7
    https://hdl.handle.net/20.500.11820/c8a198a4-d3ad-41f0-92f5-d83398a00c6a

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء